Matsui Statement on House Passage of FDA User Fee Reauthorization

f t # e
Washington, DC, July 12, 2017 | comments
Today, Congresswoman Doris Matsui (D-CA) issued the following statement on the House passage of H.R. 2430, the FDA user fee reauthorization bill: “Patients and families across the country battling diseases like Alzheimer’s, cancer, MS, and diabetes rely on innovation to provide new life-saving and life-enhancing treatments, and hopefully one day, cures.  Without the FDA, we would not be able to ensure that those treatments and cures work and that they’re safe. “Swift Congressional action to reauthorize this bill will ensure that the FDA is able to conduct its critical work to make sure that our nation’s drugs and devices are safe and effective.”


f t # e

Stay Connected

Use the form below to sign up for Congresswoman Matsui's newsletter and get the latest news and updates directly to your inbox.